Postmortem analysis of invasive aspergillosis in a tertiary care hospital M. VogeserA. HaasG. Ruckdeschel Articles Pages: 1 - 6
Comparison of polymerase chain reaction with light microscopy for detection of microsporidia in clinical specimens S. Katzwinkel-WladarschP. DeplazesH. Rinder Articles Pages: 7 - 10
Antimicrobial susceptibility ofStreptococcus pneumoniae isolated from pediatric carriers in Spain J. García-de-LomasC. GimenoB. Garijo Notes Pages: 11 - 13
Synergistic effect of azithromycin on the phagocytic killing ofStaphylococcus aureus by human polymorphonuclear leukocytes I. Herrera-InsúaP. PérezJ. Prieto Notes Pages: 13 - 16
Clearances ofCandida albicans-derived α- and β-linked mannose residues in sera from patients with candidiasis D. PoulainR. RobertD. Camus Notes Pages: 16 - 20
Serotyping and susceptibility to macrolides and other antimicrobial drugs ofStreptococcus pyogenes isolated from patients with invasive diseases in Southern Israel I. WeissZ. GorodnitzkyP. Yagupsky Notes Pages: 20 - 23
Detection ofAspergillus DNA in bronchoalveolar lavage fluid of AIDS patients by the polymerase chain reaction E. Bart-DelabesseA. Marmorat-KhuongS. Bretagne Letters Pages: 24 - 25
Oral terbinafine for treatment of pulmonaryPseudallescheria boydii infection refractory to itraconazole therapy P. E. VerweijN. J. M. CoxJ. F. G. Meis Letters Pages: 26 - 28
Practical modalities for prevention of fungal infections in cancer patients B. E. De Pauw OriginalPaper Pages: 32 - 41
Key issues concerning fungistatic versus fungicidal drugs J. R. GraybillD. S. BurgessT. C. Hardin OriginalPaper Pages: 42 - 50
Hematopoietic growth factors in cancer patients with invasive fungal infections F. Offner OriginalPaper Pages: 56 - 63
Biopharmaceutical aspects of lipid formulations of amphotericin B G. StormE. van Etten OriginalPaper Pages: 64 - 73
Diversity of lipid-based polyene formulations and their behavior in biological systems K. M. WasanG. Lopez-Berestein OriginalPaper Pages: 81 - 92
Pradimicins: A novel class of broad-spectrum antifungal compounds T. J. WalshN. Giri OriginalPaper Pages: 93 - 97
Economic aspects of treatment for fungal infections in cancer patients K. Torfs OriginalPaper Pages: 98 - 107